EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 2 May 2024

White Paper on Circular Economy

Read the White Paper on Circular Economy

The existing linear economic model of ‘take, make, use, dispose’ is neither innovative, nor sustainable.

Current estimates are that we are using the world’s scarce and non-renewable resources as if we have several planets at our disposal.

In the circular economy ‘waste’ from one process would be the input for another.

Find out more about how the pharmaceutical industry maximises the lifetime of resources, reduces waste and minimises environmental impact.

Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens

Precision oncology holds great promise: for better therapy selection, fewer side effects, and higher success rates, thereby having the potential to improve patient outcomes and cancer care efficiency. However, traditional value frameworks and approval pathways pose challenges which may limit patient access to PO therapies.

This study explores possible solutions, and provides actionable recommendations to maximize PO medicine value.

Read the full study here.

Events

Thought Leader Session: Collaborating for Change
03 May 2024 (Online session)

Transforming Rare Disease Outcomes through Public-Private Partnerships. Read more

IMI impact on antimicrobial resistance
31 May 2024 (Online event)

Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects. Read more

Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?...
04 June 2024 (Online session)

In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at... Read more

Executive MSc Healthcare Decision-Making at LSE
31 October 2024 (London, UK)

Discover the transformative Executive MSc in Healthcare Decision-Making, a dynamic partnership between NICE and LSE.... Read more

What we are reading

Digital Display Labeling in Clinical Supplies for Clinical Trials
On 15 March 2024 (ISPE)

Digital display labels will optimise drug development, accelerating patient's access to therapies.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu